logo

ICU

SeaStar MedicalยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ICU fundamentals

SeaStar Medical (ICU) released its earnings on Nov 13, 2025: revenue was 183.00K (YoY +169.12%), missed estimates; EPS was -0.13 (YoY +88.18%), beat estimates.
Revenue / YoY
183.00K
+169.12%
EPS / YoY
-0.13
+88.18%
Report date
Nov 13, 2025
ICU Earnings Call Summary for Q3,2025
  • Revenue Milestone: Q3 revenue of $183,000, on track for over $1 million in 2025, with Q4 sales surpassing Q3 levels.
  • Clinical Expansion: NEUTRALIZE-AKI trial enrolling 146/339 patients across 17 sites, targeting 25 sites by year-end.
  • Financial Strength: $13.8 million cash, raised $12.4 million, supporting clinical trial expansion.
  • Strategic Growth: Quellimune adoption in 10 commercial sites, aiming for a $100 million market with 76% patient survival rates.
EPS
Revenue

Revenue & Expenses

ICU has released its 2025 Q3 earnings report, with revenue of 183.00K, reflecting a YoY change of 169.12%, and net profit of -3.47M, showing a YoY change of 22.47%. The Sankey diagram below clearly presents ICU's revenue sources and cost distribution.

Key Indicators

SeaStar Medical (ICU) key financial stats and ratios, covering profitability, financial health, and leverage.
SeaStar Medical (ICU)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
SeaStar Medical (ICU)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
SeaStar Medical (ICU)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does SeaStar Medical (ICU) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track SeaStar Medical (ICU) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield